- Home
- NMTC vs BRNS Comparison
NMTC vs BRNS Comparison
Compare NMTC & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- BRNS
- Stock Information
- Founded
- NMTC 2009
- BRNS 2016
- Country
- NMTC United States
- BRNS United Kingdom
- Employees
- NMTC N/A
- BRNS N/A
- Industry
- NMTC Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- BRNS Health Care
- Exchange
- NMTC Nasdaq
- BRNS Nasdaq
- Market Cap
- NMTC 33.8M
- BRNS 36.0M
- IPO Year
- NMTC N/A
- BRNS 2021
- Fundamental
- Price
- NMTC $0.72
- BRNS $1.05
- Analyst Decision
- NMTC Strong Buy
- BRNS Strong Buy
- Analyst Count
- NMTC 1
- BRNS 1
- Target Price
- NMTC $1.45
- BRNS $3.00
- AVG Volume (30 Days)
- NMTC 180.3K
- BRNS 16.3K
- Earning Date
- NMTC 08-13-2025
- BRNS 08-07-2025
- Dividend Yield
- NMTC N/A
- BRNS N/A
- EPS Growth
- NMTC N/A
- BRNS N/A
- EPS
- NMTC N/A
- BRNS N/A
- Revenue
- NMTC $5,758,777.00
- BRNS $14,969,000.00
- Revenue This Year
- NMTC $141.04
- BRNS N/A
- Revenue Next Year
- NMTC $38.86
- BRNS N/A
- P/E Ratio
- NMTC N/A
- BRNS N/A
- Revenue Growth
- NMTC 54.53
- BRNS 4381.74
- 52 Week Low
- NMTC $0.40
- BRNS $0.64
- 52 Week High
- NMTC $1.39
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- NMTC 63.09
- BRNS 57.55
- Support Level
- NMTC $0.68
- BRNS $0.90
- Resistance Level
- NMTC $0.77
- BRNS $1.05
- Average True Range (ATR)
- NMTC 0.05
- BRNS 0.06
- MACD
- NMTC 0.01
- BRNS 0.01
- Stochastic Oscillator
- NMTC 73.64
- BRNS 71.96
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.